Related Experiment Video
Updated: May 22, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
In-line filtration reduces severe complications and length of stay on pediatric intensive care unit: a prospective,
Thomas Jack1, Martin Boehne, Bernadette E Brent
1Department of Pediatric Cardiology and Intensive Care Medicine, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany.
Insights
In-line filtration of intravenous fluids significantly reduced complications and systemic inflammatory response syndrome (SIRS) in critically ill children. This intervention also shortened pediatric intensive care unit (PICU) stays and mechanical ventilation duration.
Area of Science:
- Critical Care Medicine
- Pediatric Intensive Care
- Medical Device Technology
Background:
- Particulate contamination in intravenous fluids poses health risks to intensive care patients.
- Infusion therapy is a common practice in pediatric intensive care units (PICUs).
Purpose of the Study:
- To assess the impact of in-line filtration of intravenous fluids on reducing complications in critically ill children.
- To evaluate the effect of filtration on systemic inflammatory response syndrome (SIRS), sepsis, organ failure, and thrombosis.
Main Methods:
- A prospective, randomized controlled trial involving 807 children admitted to a PICU.
- Subjects were assigned to either a control group or a group receiving in-line filtration.
- Primary endpoint: reduction in overall complication rate; secondary endpoints: length of stay and duration of mechanical ventilation.
Main Results:
- The filter group showed a significant reduction in overall complications (30.9% vs. 40.9%).
- Incidence of SIRS was significantly lower in the filter group (22.4% vs. 30.3%).
- PICU length of stay and duration of mechanical ventilation were significantly reduced in the filter group.
Conclusions:
- In-line filtration of intravenous fluids is effective in preventing severe complications in critically ill pediatric patients.
- Filtration improves the safety of intensive care therapy by reducing SIRS and overall complications.
- This preventive strategy leads to shorter PICU stays and reduced mechanical ventilation duration.
Purpose:
Particulate contamination due to infusion therapy carries a potential health risk for intensive care patients.
Methods:
This single-centre, prospective, randomized controlled trial assessed the effects of filtration of intravenous fluids on the reduction of complications in critically ill children admitted to a pediatric intensive care unit (PICU). A total of 807 subjects were randomly assigned to either a control (n = 406) or filter group (n = 401), with the latter receiving in-line filtration. The primary endpoint was reduction in the rate of overall complications, which included the occurrence of systemic inflammatory response syndrome (SIRS), sepsis, organ failure (circulation, lung, liver, kidney) and thrombosis. Secondary objectives were a reduction in the length of stay on the PICU and overall hospital stay. Duration of mechanical ventilation and mortality were also analyzed.
Findings:
Analysis demonstrated a significant reduction in the overall complication rate (n = 166 [40.9 %] vs. n = 124 [30.9 %]; P = 0.003) for the filter group. In particular, the incidence of SIRS was significantly lower (n = 123 [30.3 %] vs. n = 90 [22.4 %]; P = 0.01). Moreover the length of stay on PICU (3.89 [95 % confidence interval 2.97-4.82] vs. 2.98 [2.33-3.64]; P = 0.025) and duration of mechanical ventilation (14.0 [5.6-22.4] vs. 11.0 [7.1-14.9] h; P = 0.028) were significantly reduced.
Conclusion:
In-line filtration is able to avert severe complications in critically ill patients. The overall complication rate during the PICU stay among the filter group was significantly reduced. In-line filtration was effective in reducing the occurrence of SIRS. We therefore conclude that in-line filtration improves the safety of intensive care therapy and represents a preventive strategy that results in a significant reduction of the length of stay in the PICU and duration of mechanical ventilation (ClinicalTrials.gov number: NCT00209768).
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
Acute Kidney Injury V: Interprofessional Care
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Filtration